Interesting facts
Interesting Facts about [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate
This compound is a fascinating molecule that encompasses several intriguing features, reflecting its potential importance in various fields of research.
Chemical Structure and Functionality
- Chiral Centers: The presence of multiple chiral centers indicates that this compound can exist in enantiomeric forms. This characteristic is crucial in pharmaceuticals, as it can lead to varying biological activities between enantiomers.
- Pyridine Derivative: The incorporation of a carbamoylpyridin-1-ium moiety may enhance the compound's interaction with biological molecules, making it a good candidate for drug development.
- Hydrogen Phosphate Group: The hydrogen phosphate group is essential in energy transfer and metabolism, indicating that this compound could play a role in biochemistry.
Biological Relevance
This compound's structure suggests various applications, particularly in the realm of pharmaceuticals and biochemistry:
- It may serve as a precursor or active component in the development of novel therapeutic agents.
- The dual hydroxyl groups might offer potential for hydrogen bonding, influencing interactions with enzymes or receptor sites.
Research Potential
Given its complex structure, this compound can be a subject of numerous research endeavors:
- Protein Interactions: Studies can be conducted to evaluate how this compound interacts with specific proteins or enzymes in metabolic pathways.
- Drug Design: The unique structure can be explored for its efficacy in targeting diseases, particularly those related to the nervous system, thanks to the pyridine component.
In summary, the compound [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate offers a rich tapestry of structural features and potential applications. Its multifaceted nature positions it as a significant player in both chemical research and biomedical applications.
Synonyms
1094-61-7
nicotinamide mononucleotide
Nicotinamide ribotide
beta-NMN
2KG6QX4W0V
EINECS 214-136-5
.BETA.-NMN
.BETA.-D-NMN
Pyridinium, 3-(aminocarbonyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)-, inner salt
DTXSID50911152
Nicotinamide ribonucleoside 5'-phosphate
3-(Aminocarbonyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridinium inner salt
3-(AMINOCARBONYL)-1-(5-O-PHOSPHONO-.BETA.-D-RIBOFURANOSYL)PYRIDINIUM INNER SALT
3-carbamoyl-1-[(2R,3R,4S,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1$l^{5}-pyridin-1-ylium
Mononucleotide, Nicotinamide
Pyridinium, 3-(aminocarbonyl)-1-(5-O-phosphono-.beta.-D-ribofuranosyl)-, inner salt
3-carbamoyl-1-((2R,3R,4S,5R)-5-((hydrogen phosphonatooxy)methyl)-3,4-dihydroxyoxolan-2-yl)-1$l^(5)-pyridin-1-ylium
3-carboxy-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-((phosphonooxy)methyl)oxolan-2-yl)-1lambda5-pyridin-1-ylium
3-carboxy-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1lambda5-pyridin-1-ylium
ELITEHEALTH
REUS NR
BETA-D-NMN
CHEBI:50383
DTXCID001511294
beta-Nicotinamide mononucleotide
NMN zwitterion
NMN
nicotinamide nucleotide
beta-nicotinamide D-ribonucleotide
nicotinamide ribonucleotide
nicotinamide D-ribonucleotide
beta-Nicotinamide ribonucleotide
((2R,3S,4R,5R)-5-(3-Carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen phosphate
CHEBI:16171
3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium
B-NICOTINAMIDE MONONUCLEOTIDE
beta-nicotinamide ribose monophosphate
MFCD00038748
UNII-2KG6QX4W0V
reinvigorator
[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate
ss-NMN
BETANMN
Nicotinamidmononucleotid
-NM;NMN
bmse000260
-Nicotinamide mononucleotide
?-Nicotinamidemononucleotide
Nicotinamide Mononucleotide?
NMN [MI]
ss-Nicotinamide mononucleotide
fA-Nicotinamide Mononucleotide
SCHEMBL105618
CHEMBL610238
SCHEMBL26106427
beta -Nicotinamide mononucleotide
GLXC-21427
EX-A3534
HY-F0004
BDBM50366763
|A-Nicotinamide Mononucleotide (NMN)
AKOS015896881
CCG-267847
CS-4996
NN45555
3-carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide 5'-(dihydrogen phosphate) inner salt
AC-35057
AS-59655
1ST157075
N1123
C00455
H11919
Q21547155
3-carbamoyl-1-[5-O-(hydroxyphosphinato)-beta-D-ribofuranosyl]pyridinium
3-(aminocarbonyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridinium, inner salt
((2R,3S,4R,5R)-5-(3-carbamoylpyridinium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen phosphate
[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methylhydrogenphosphate
3-carbamoyl-1-[(2R,3R,4S,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1??-pyridin-1-ylium
AfAE'A centa' notA inverted exclamation markAfasA'A|AfAE'Adaggeratrade markAfA centA centasA notA em leaderA inverted exclamation mark-Nicotinamide mononucleotide
Nicotinamide ribonucleoside 5'-phosphate;b-Nicotinamide ribose monophosphate;Nicotinamide ribotide;b-D-NMN
Solubility Overview
The compound [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate is a complex molecule with interesting solubility characteristics influenced by its intricate structure.
Factors Affecting Solubility
Several factors contribute to the solubility of this compound:
Expected Solubility
Given these factors, it is likely that this compound exhibits:
To summarize, the solubility of this compound will largely depend on the solvent's polarity and the ability of the functional groups to interact through hydrogen bonding and ionic interactions, leading to an interesting exploration in solubility behavior.